K831905

Substantially Equivalent

RABBITT ANTISERUM TO HUMAN C3C

Applicant: Dako Corp.
Product code: CZW
Advisory panel: Immunology
Date received: 1983-06-14
Decision date: 1983-07-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.